Class action deadline approaching: berger montague advises regeneron pharmaceuticals (nasdaq: regn) investors to inquire about a securities fraud class action by march 10, 2025

Philadelphia , march 5, 2025 /prnewswire/ -- berger montague pc advises investors that a securities class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) on behalf of purchasers of regeneron securities between november 2, 2023 through october 30, 2024, inclusive (the "class period"). investor deadline: investors who purchased or acquired regeneron securities during the class period may, no later than march 10, 2025 , seek to be appointed as a lead plaintiff representative of the class.
REGN Ratings Summary
REGN Quant Ranking